133 related articles for article (PubMed ID: 10517497)
21. The potential role of amifostine (Ethyol) in haematological malignancies.
Gorin NC
Eur J Cancer; 1996; 32A Suppl 4():S31-9. PubMed ID: 8976820
[TBL] [Abstract][Full Text] [Related]
22. Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
Valeriote F; Tolen S
Cancer Res; 1982 Nov; 42(11):4330-1. PubMed ID: 6290032
[TBL] [Abstract][Full Text] [Related]
23. Amifostine promotes hemopoietic progenitor cell mobilization in patients with myelodysplastic syndrome.
Arboscello E; Botta M; Lerza R; Bogliolo G; Clavio M; Miglino M; Mencoboni M; Pannacciulli I
Anticancer Res; 2002; 22(3):1819-24. PubMed ID: 12168875
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
25. Ex-vivo purging of hematopoietic progenitor cells.
de Lima M; Shpall EJ
Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
[TBL] [Abstract][Full Text] [Related]
26. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.
Capizzi RL; Scheffler BJ; Schein PS
Cancer; 1993 Dec; 72(11 Suppl):3495-501. PubMed ID: 8242582
[TBL] [Abstract][Full Text] [Related]
27. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
28. Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. implications for bone marrow purging.
Lydaki E; Dimitriou H; Papazoglou T; Liu WQ; Kalmanti M
Leuk Res; 1997 Jul; 21(7):641-50. PubMed ID: 9301685
[TBL] [Abstract][Full Text] [Related]
29. Future paradigm for autologous bone marrow transplantation: tumor purging and ex vivo production of normal stem and progenitor cells.
Rummel SA; Van Zant G
J Hematother; 1994; 3(3):213-8. PubMed ID: 7827869
[TBL] [Abstract][Full Text] [Related]
30. A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
Ferrero D; Tarella C; Cherasco C; Bondesan P; Omedè P; Ravaglia R; Caracciolo D; Castellino C; Pileri A
Bone Marrow Transplant; 1998 Feb; 21(4):409-13. PubMed ID: 9509977
[TBL] [Abstract][Full Text] [Related]
31. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
32. Negative selection and protection of normal progenitor cells for autografting.
Douay L
Bone Marrow Transplant; 1998 Sep; 22(5):423-30. PubMed ID: 9733264
[TBL] [Abstract][Full Text] [Related]
33. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma.
Yang H; Robinson SN; Nieto Y; Jones RJ; Gocke CD; Lu J; Giralt SA; Jones RB; Decker WK; Xing D; Steiner D; Champlin RE; McMannis JD; Ng J; Thomas MW; Shah N; Andersson BS; Parmar S; Shpall EJ
Cancer Res; 2011 Jul; 71(14):5040-9. PubMed ID: 21646477
[TBL] [Abstract][Full Text] [Related]
35. Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia.
List AF
Semin Oncol; 1999 Apr; 26(2 Suppl 7):61-5. PubMed ID: 10348262
[TBL] [Abstract][Full Text] [Related]
36. Amifostine stimulates the formation of hematopoietic bone marrow progenitors from B-cell chronic lymphocytic leukemia.
Tsatalas C; Spanoudakis E; Pantelidou D; Margaritis D; Kotsianidis I; Chalkia P; Tripsianis G; Basdiara I; Kartasis Z; Karakolios A; Bourikas G
Acta Haematol; 2004; 112(3):136-40. PubMed ID: 15345895
[TBL] [Abstract][Full Text] [Related]
37. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
Naujokaitis SA; Fisher JM; Rabinovitz M
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
[TBL] [Abstract][Full Text] [Related]
38. Clinical status of the new cytoprotective agent, amifostine.
Kalaycioglu M; Bukowski R
Oncology (Williston Park); 1994 Jul; 8(7):15-6, 19-20, 23. PubMed ID: 7522504
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow purging by photodynamic treatment in children with acute leukemia: cytoprotective action of amifostine.
Danilatou V; Lydaki E; Dimitriou H; Papazoglou T; Kalmanti M
Leuk Res; 2000 May; 24(5):427-35. PubMed ID: 10785265
[TBL] [Abstract][Full Text] [Related]
40. Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation.
Ramdas J; Warrier RP; Scher C; Larussa V
J Pediatr Hematol Oncol; 2003 Jan; 25(1):19-26. PubMed ID: 12544769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
